Hdl Handle:
http://hdl.handle.net/10147/200263
Title:
Perioperative anaphylaxis.
Authors:
Mertes, P M; Tajima, K; Regnier-Kimmoun, M A; Lambert, M; Iohom, G; Guéant-Rodriguez, R M; Malinovsky, J M
Affiliation:
Service d'Anesthésie-Réanimation Chirurgicale, CHU de Nancy, Hôpital Central, 29 Avenue de Lattre de Tassigny, 54035 Nancy Cedex, France. pm.mertes@chu-nancy.fr
Citation:
Perioperative anaphylaxis. 2010, 94 (4):761-89, xi Med. Clin. North Am.
Publisher:
Elsevier
Journal:
The Medical clinics of North America
Issue Date:
Jul-2010
URI:
http://hdl.handle.net/10147/200263
DOI:
10.1016/j.mcna.2010.04.002
PubMed ID:
20609862
Abstract:
The incidence of immune-mediated anaphylaxis during anesthesia ranges from 1 in 10,000 to 1 in 20,000. Neuromuscular blocking agents are most frequently incriminated, followed by latex and antibiotics, although any drug or substance used may be a culprit. Diagnosis relies on tryptase measurements at the time of the reaction and skin tests, specific immunoglobulin E, or basophil activation assays. Treatment consists of rapid volume expansion and epinephrine administration titrated to symptom severity.
Item Type:
Article
Language:
en
MeSH:
Adrenergic Agonists; Analgesics, Opioid; Anaphylaxis; Anesthesia; Anesthetics, Local; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aprotinin; Basophils; Epinephrine; Fluid Therapy; Humans; Hypnotics and Sedatives; Immunoglobulin E; Intraoperative Complications; Latex; Neuromuscular Blocking Agents; Risk Factors; Serine Proteinase Inhibitors; Skin Tests; Tryptases
ISSN:
1557-9859

Full metadata record

DC FieldValue Language
dc.contributor.authorMertes, P Men
dc.contributor.authorTajima, Ken
dc.contributor.authorRegnier-Kimmoun, M Aen
dc.contributor.authorLambert, Men
dc.contributor.authorIohom, Gen
dc.contributor.authorGuéant-Rodriguez, R Men
dc.contributor.authorMalinovsky, J Men
dc.date.accessioned2012-01-05T12:39:30Z-
dc.date.available2012-01-05T12:39:30Z-
dc.date.issued2010-07-
dc.identifier.citationPerioperative anaphylaxis. 2010, 94 (4):761-89, xi Med. Clin. North Am.en
dc.identifier.issn1557-9859-
dc.identifier.pmid20609862-
dc.identifier.doi10.1016/j.mcna.2010.04.002-
dc.identifier.urihttp://hdl.handle.net/10147/200263-
dc.description.abstractThe incidence of immune-mediated anaphylaxis during anesthesia ranges from 1 in 10,000 to 1 in 20,000. Neuromuscular blocking agents are most frequently incriminated, followed by latex and antibiotics, although any drug or substance used may be a culprit. Diagnosis relies on tryptase measurements at the time of the reaction and skin tests, specific immunoglobulin E, or basophil activation assays. Treatment consists of rapid volume expansion and epinephrine administration titrated to symptom severity.-
dc.language.isoenen
dc.publisherElsevieren
dc.subject.meshAdrenergic Agonists-
dc.subject.meshAnalgesics, Opioid-
dc.subject.meshAnaphylaxis-
dc.subject.meshAnesthesia-
dc.subject.meshAnesthetics, Local-
dc.subject.meshAnti-Bacterial Agents-
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidal-
dc.subject.meshAprotinin-
dc.subject.meshBasophils-
dc.subject.meshEpinephrine-
dc.subject.meshFluid Therapy-
dc.subject.meshHumans-
dc.subject.meshHypnotics and Sedatives-
dc.subject.meshImmunoglobulin E-
dc.subject.meshIntraoperative Complications-
dc.subject.meshLatex-
dc.subject.meshNeuromuscular Blocking Agents-
dc.subject.meshRisk Factors-
dc.subject.meshSerine Proteinase Inhibitors-
dc.subject.meshSkin Tests-
dc.subject.meshTryptases-
dc.titlePerioperative anaphylaxis.en
dc.typeArticleen
dc.contributor.departmentService d'Anesthésie-Réanimation Chirurgicale, CHU de Nancy, Hôpital Central, 29 Avenue de Lattre de Tassigny, 54035 Nancy Cedex, France. pm.mertes@chu-nancy.fren
dc.identifier.journalThe Medical clinics of North Americaen
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.